Welsh Renal Clinical Network, Cwm Taf Morgannwg University Health Board, Caerphilly, UK.
Department of Clinical Biochemistry, Cwm Taf Morgannwg University Health Board, Merthyr, UK.
Nephrol Dial Transplant. 2020 Aug 1;35(8):1361-1369. doi: 10.1093/ndt/gfz155.
This study examined the impact of recurrent episodes of acute kidney injury (AKI) on patient outcomes.
The Welsh National electronic AKI reporting system was used to identify all cases of AKI in patients ≥18 years of age between April 2015 and September 2018. Patients were grouped according to the number of AKI episodes they experienced with each patient's first episode described as their index episode. We compared the demography and patient outcomes of those patients with a single AKI episode with those patients with multiple AKI episodes. Analysis included 153 776 AKI episodes in 111 528 patients.
Of those who experienced AKI and survived their index episode, 29.3% experienced a second episode, 9.9% a third episode and 4.0% experienced fourth or more episodes. Thirty-day mortality for those patients with multiple episodes of AKI was significantly higher than for those patients with a single episode (31.3% versus 24.9%, P < 0.001). Following a single episode, recovery to baseline renal function at 30 days was achieved in 83.6% of patients and was significantly higher than for patients who had repeated episodes (77.8%, P < 0.001). For surviving patients, non-recovery of renal function following any AKI episode was significantly associated with a higher probability of a further AKI episode (33.4% versus 41.0%, P < 0.001). Furthermore, with each episode of AKI the likelihood of a subsequent episode also increased (31.0% versus 43.2% versus 51.2% versus 51.7% following a first, second, third and fourth episode, P < 0.001 for all comparisons).
The results of this study provide an important contribution to the debate regarding the need for risk stratification for recurrent AKI. The data suggest that such a tool would be useful given the poor patient and renal outcomes associated with recurrent AKI episodes as highlighted by this study.
本研究旨在探讨急性肾损伤(AKI)反复发作对患者预后的影响。
采用威尔士国家电子 AKI 报告系统,对 2015 年 4 月至 2018 年 9 月期间≥18 岁的 AKI 患者进行了所有病例的识别。根据患者经历 AKI 发作的次数将患者分为不同组,每位患者的首次发作被描述为其指数发作。我们比较了首次 AKI 发作的患者和多次 AKI 发作的患者的人口统计学和患者结局。分析共纳入 111528 例患者的 153776 次 AKI 发作。
在经历 AKI 且存活过指数发作的患者中,29.3%经历了第二次发作,9.9%经历了第三次发作,4.0%经历了第四次或更多次发作。多次 AKI 发作患者的 30 天死亡率明显高于首次 AKI 发作患者(31.3%比 24.9%,P<0.001)。首次 AKI 发作后,30 天内恢复至基线肾功能的患者占 83.6%,明显高于多次 AKI 发作患者(77.8%,P<0.001)。对于存活的患者,任何一次 AKI 发作后肾功能未恢复与再次发生 AKI 发作的可能性更高显著相关(33.4%比 41.0%,P<0.001)。此外,每次 AKI 发作后,再次发生 AKI 的可能性也会增加(首次、第二次、第三次和第四次发作后分别为 31.0%、43.2%、51.2%和 51.7%,所有比较 P<0.001)。
本研究结果为急性肾损伤反复发作的风险分层是否必要的争论提供了重要依据。数据表明,鉴于该研究强调的反复发作 AKI 与患者和肾脏结局较差相关,这种工具可能是有用的。